Vyne Therapeutics Inc Working Capital to Net Assets Ratio
Vyne Therapeutics Inc working capital to net assets ratio. Vyne Therapeutics Inc (VYNE) has a Working Capital to Net Assets ratio of 99.5% as of December 2025. Working capital of $27.61 Million (current assets of $30.01 Million minus current liabilities of $2.40 Million) is measured against net assets of $27.77 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check how tangible is Vyne Therapeutics Inc's equity to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Vyne Therapeutics Inc (2015–2025)
Working capital to net assets ratio of Vyne Therapeutics Inc from 2015 to 2025. This chart shows how Vyne Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of December 2025, the ratio stands at 99.5%, reflecting working capital of $27.61 Million against net assets of $27.77 Million USD. See VYNE defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Vyne Therapeutics Inc Working Capital to Net Assets Ratio by Year (2015–2025)
Vyne Therapeutics Inc working capital to net assets ratio by year from 2015 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Vyne Therapeutics Inc from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see VYNE total asset value.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 99.5% | $27.61 Million | $27.77 Million | $30.01 Million | $2.40 Million | ▲ +4.2 pp |
| 2024 | 95.3% | $49.62 Million | $52.09 Million | $64.44 Million | $14.82 Million | ▼ -4.4 pp |
| 2023 | 99.7% | $88.42 Million | $88.73 Million | $95.96 Million | $7.54 Million | ▲ +6.9 pp |
| 2022 | 92.7% | $28.93 Million | $31.20 Million | $38.27 Million | $9.35 Million | ▲ +0.7 pp |
| 2021 | 92.1% | $44.78 Million | $48.64 Million | $63.19 Million | $18.41 Million | ▼ -82.6 pp |
| 2020 | 174.7% | $65.49 Million | $37.49 Million | $87.26 Million | $21.77 Million | ▲ +75.9 pp |
| 2019 | 98.8% | $67.67 Million | $68.51 Million | $78.33 Million | $10.66 Million | ▼ -0.9 pp |
| 2018 | 99.7% | $129.96 Million | $130.38 Million | $139.50 Million | $9.54 Million | ▲ +197.9 pp |
| 2017 | -98.3% | $56.04 Million | $-57.03 Million | $63.86 Million | $7.82 Million | ▼ -4.4 pp |
| 2016 | -93.9% | $27.64 Million | $-29.44 Million | $31.54 Million | $3.90 Million | ▲ +176.4 pp |
| 2015 | -270.3% | $43.12 Million | $-15.95 Million | $43.88 Million | $770.00K | — |